Two clinically-relevant markers of dementia, β-amyloid and PHF-tau, were profiled in 10 brain tissue sections from an “Alzheimer’s disease” cohort and compared to 9 “Control” specimens. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.